CLINICAL_TRIALS
trial_result
· 2018-07-31
Clinical Trial Update: 21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus [Phase 2]
Summary
A Phase 2 trial comparing continuous insulin infusion with HDV insulin to standard insulin in type 1 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Diasome Pharmaceuticals | Conditions: Type1 Diabetes Mellitus | Phase 2 | Status: COMPLETED